Market Research Logo

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products
Report Scope:

The report focuses on select drugs (antimicrobials), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (e.g. catheters, patient ventilation devices, sterile IV filters) that prevent occurrence of nosocomial infections.

Within each type of treatment, regional analyses will focus on the Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa) and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries).

Report Includes:

- 42 data tables and 32 additional tables
- Industry analysis of the global healthcare-acquired infection (HCAI) control market
- Detailed overview and trend analysis of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent these infections
- Analyses of global market trends with data from 2017, estimates for 2018 and projections of compound annual growth rates (CAGRs) through 2023
- Emphasis on selected devices, pharmaceuticals and environmental products currently employed or under development for treatment of viral, bacterial and fungal infections
- Analysis of antimicrobial resistance and more specifically antibiotic resistance as a cause for these infections
- A look at the hospital surveillance methods and tools currently being used to prevent these infections
- Regional analysis of the market covering Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa); and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries)
- Information on key patents and newer research developments in sterilization systems and devices
- Examination of vendor landscape and profiles of key players in the HCAI market, including Novartis, Pfizer, Roche, 3M Healthcare and Sanofi Pasteur


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
Healthcare-Acquired Infections
Types of Infections
Central-Line-Associated Bloodstream Infections
Surgical Site Infections
Catheter-Associated Urinary Tract Infections
Ventilator-Associated Pneumonia
Diseases and Infectious Agents in Healthcare Settings
Acinetobacter
Burkholderia cepacia
Clostridium difficile
Clostridium sordellii
Enterobacteriaceae (Carbapenem-Resistant)
Gram-Negative Bacteria
Hepatitis
HIV/AIDS
Influenza
Klebsiella
Methicillin-Resistant Staphylococcus aureus
Mycobacterium abscessus
Norovirus
Pseudomonas aeruginosa
Staphylococcus aureus
Vancomycin-Resistant Enterococci
Incidence and Prevalence
Risk Factors
Prevention Strategies
Basic Infection Prevention and Control
Antibiotics and Multidrug-Resistant Organisms
Device-Associated Infection Control
Procedure-Associated Guidelines
Setting Specific Guidelines
WHO Guidelines
Surveillance Systems
Chapter 4 Market Summary and Analysis
Global Infection control Market
Region-wise Analysis
Market Drivers
Antimicrobial Resistance
Increasing Population and Demographic Changes
Emerging Markets
New Technologies
Vaccine Coverage
Increase in Focus on HCAIs
Market Deterrents
Cost-Effectiveness of Newer Methods
Unmet Needs
Effective Treatment for Superbugs
Chapter 5 Pharmaceuticals
HCAI Pharmaceuticals Market
Antibiotics
Mechanism of Action
Antibiotics Resistance
Mechanisms of Antibiotic Resistance
Reasons for Antibiotic Resistance
Antimicrobial Resistance (Antibiotics) -- Incidence
Antibiotic Resistance -- Hospitals, Healthcare Settings
Davos Declaration for Combating Antimicrobial Resistance
Antibiotics for Bacterial HCAI
Select Marketed Antibiotics
Global Antibiotics Market
Antifungal Drugs
Antifungals for HCAI
Select Marketed Antifungals
Global Antifungals Market
Antivirals and Vaccines
Hepatitis B and Hepatitis C
Influenza
Chapter 6 Environmental Treatment
HCAI: Environmental Treatment Market
Disinfectants
Key Marketed Hospital-Use Disinfectants
Patient Skin Preparation
Key Marketed Patient Skin Preparation Antiseptics
Patient Skin Preparation Market
Environment Sterilization
Air Treatment
Room Filtration Systems
Room Pressurization
UV Light Disinfection
Water Treatment
Equipment/Facility Sterilization
Heat Sterilization
Chemical Sterilization
Radiation-based Sterilization
Environment Sterilization Market
Chapter 7 Medical Devices
HCAI: Medical Devices Market
Antimicrobial Coatings
Catheters
Patient Ventilation Devices
Types of Ventilation Devices
IV Filters
IV Filter Market
Chapter 8 Industry Structure
Industry Structure for Healthcare Infection Prevention
Suppliers
Customers
Consumers
Chapter 9 Research and Opportunities
New Technologies
Hand Hygiene
Patient Tracing
Self-Disinfecting Surfaces
Automated Decontamination Technologies
Smart Systems and Predictive Analytics
Other Technologies
Antibiotics Pipeline
Viral Infection Pipeline -- Hepatitis B and Hepatitis C
Pipeline of Viral Infection Influenza
Fungal Infection Pipeline
Chapter 10 Patent Analysis
Pharmaceuticals
Antibiotics
Hepatitis B
Hepatitis C
Influenza
Antifungals
Environment Sterilization
Disinfectants
Patient Skin Preparation
Air Treatment
Water Treatment
Medical Devices
Catheters and Endotracheal Tubes
IV Filters (In-Line)
Chapter 11 Company Profiles
Pharmaceutical Companies
GILEAD SCIENCES
MERCK
NOVARTIS
PFIZER
ROCHE
SANOFI, SANOFI PASTEUR
SEQIRUS
Companies in Sterilization/Disinfection Industry
3M HEALTHCARE
ADVANCED STERILIZATION PRODUCTS
BECTON, DICKINSON AND COMPANY
BELIMED
STERIGENICS
THE CLOROX COMPANY
XENEX DISINFECTION SERVICES
Medical Device Companies
BACTIGUARD
TELEFLEX
Chapter 12 Appendix
List of Tables
Summary Table A : Global Market for HCAI Control, by Segment, Through 2023
Summary Table B : Global Market for HCAI Control, by Region, Through 2023
Table 1 : Pooled Cumulative Incidence Density, HCAI and Device-Associated Infections in Adults, 1995-2010
Table 2 : HCAIs, LTACHs and IRFs in the U.S., 2014
Table 3 : SSI Rates for Select Procedures, U.S., 2014
Table 4 : Sterilization and Disinfection Methods, CDC Guidelines, Updated February 2017
Table 5 : Air-Handling Systems in Healthcare, CDC Recommendations, Updated February 2017
Table 6 : Controlling Spread of Waterborne Infections, CDC Recommendations, Updated February 2017
Table 7 : Routine Prevention of Waterborne Microbial Contamination Within the Distribution System, CDC Recommendations, Updated February 2017
Table 8 : Proportion of Resistant Strains, by WHO Region
Table 9 : WHO Priority List, Pathogens for R&D of New Antibiotics
Table 10 : Administrative Measures, MDROs, CDC Recommendations, Updated 2006
Table 11 : Education and Training, MDROs, CDC Recommendations, Updated 2006
Table 12 : Judicious Use of Antimicrobial Agents, MDROs, CDC Recommendations, Updated 2006
Table 13 : Surveillance, MDROs, CDC Recommendations, Updated 2006
Table 14 : Appropriate Urinary Catheter Use, CDC Recommendations, Updated 2009
Table 15 : Urinary Catheter Maintenance, CDC Recommendations, Updated 2009
Table 16 : Summary of Recommendations, CRBSI, CDC, Updated 2011
Table 17 : SSI, CDC Recommendations, Updated 2017
Table 18 : Dialysis, CDC Recommendations, Updated 2016
Table 19 : Core Components of IPC Programs at the National and Acute Healthcare Facility Level, HCAI, WHO Recommendations, Updated 2016
Table 20 : Surveillance Elements and Methodology, CDC, Updated 2006
Table 21 : Global Market for HCAI Control, by Segment, Through 2023
Table 22 : Global Market for HCAI Control, by Region, Through 2023
Table 23 : Global Market for HCAI Pharmaceuticals, by Category, Through 2023
Table 24 : Proportion of Resistant Strains, by WHO Region
Table 25 : WHO Priority List, Pathogens for R&D of New Antibiotics
Table 26 : Select Branded Antibiotics, by Manufacturer
Table 27 : Global Market for HCAI Antibiotics, by Class (ATC Code), Through 2023
Table 28 : Global Market for HCAI Antibiotics, by Region, Through 2023
Table 29 : Select Branded Antifungals, by Manufacturer
Table 30 : Global Market for HCAI Antifungals, by Class, Through 2023
Table 31 : Global Market for HCAI Antifungals, by Region, Through 2023
Table 32 : Key Marketed Hepatitis B Drugs
Table 33 : Global Market for Hepatitis B Therapeutics for HCAI, by Region, Through 2023
Table 34 : Global Market for Hepatitis B Vaccines for HCAI, by Region, Through 2023
Table 35 : Key Marketed Hepatitis C Drugs
Table 36 : Global Market for Hepatitis C Therapeutics for HCAI, by Region, Through 2023
Table 37 : Key Marketed Influenza Vaccines
Table 38 : Key Marketed Antivirals for Influenza
Table 39 : Global Market for Influenza Vaccines for HCAI, by Region, Through 2023
Table 40 : Global Market for HCAI Environment Treatment, by Category, Through 2023
Table 41 : Select Branded Disinfectants, by Manufacturer
Table 42 : Global Market for Disinfectant Use in Hospitals, by Region, Through 2023
Table 43 : Select Branded Skin Antiseptics (Preoperative Care), by Manufacturer
Table 44 : Global Market for Presurgical Skin Preparation, by Region, Through 2023
Table 45 : Global Market for Air-Filtration for Hospital Use, by Region, Through 2023
Table 46 : Global Market for High-Temperature Sterilization, by Region, Through 2023
Table 47 : Global Market for Low-Temperature Sterilization, by Category, Through 2023
Table 48 : Global Market for Low-Temperature Sterilization, by Region, Through 2023
Table 49 : Global Market for Radiation-based Sterilization, by Category, Through 2023
Table 50 : Global Market for Radiation-based Sterilization, by Region, Through 2023
Table 51 : Global Market for HCAI Medical Devices, by Category, Through 2023
Table 52 : Global Market for Coated Catheter, by Category, Through 2023
Table 53 : Global Market for Coated Catheter, by Region, Through 2023
Table 54 : Global Market for Coated Endotracheal Tube, by Region, Through 2023
Table 55 : Global Market for IV Filter, by Region, Through 2023
Table 56 : Global Antibiotics Development Pipeline
Table 57 : Hepatitis B and Hepatitis C Clinical Pipeline
Table 58 : Influenza A and Influenza B Clinical Pipeline
Table 59 : Antifungal Clinical Pipeline
Table 60 : Number of Published Patent Applications for Antibiotics, 2014-2017
Table 61 : Number of Published Patent Applications for Hepatitis B, 2014-2017
Table 62 : Number of Published Patent Applications for Hepatitis C, 2014-2017
Table 63 : Number of Published Patent Applications for Influenza, 2014-2017
Table 64 : Number of Published Patent Applications for Antifungals, 2014-2017
Table 65 : Number of Published Patent Applications for Disinfectants, 2014-2017
Table 66 : Number of Published Patent Applications for Patient Skin Preparation, 2014-2017
Table 67 : Number of Published Patent Applications for Air Treatment, 2014-2017
Table 68 : Number of Published Patent Applications for Water Treatment, 2014-2017
Table 69 : Number of Published Patent Applications for Catheters and ETTs, 2014-2017
Table 70 : Abbreviations Used in Global Markets for Infectious Diseases
Table 71 : Glossary of Terms Used in Global Markets for Infectious Diseases
Table 72 : Report Sources
List of Figures
Summary Figure A : Global Market for HCAI Control, by Segment, 2017-2023
Summary Figure B : Global Market for HCAI Control, by Region, 2017-2023
Figure 1 : Antibiotic Use* by Class, Select Classes, 2000 and 2010
Figure 2 : Global Market for HCAI Control, by Segment, 2017-2023
Figure 3 : Global Market for HCAI Control, by Region, 2017-2023
Figure 4 : Global Market for HCAI Pharmaceuticals, by Category, 2017-2023
Figure 5 : Antibiotic Use* by Class, Select Classes, 2000 and 2010
Figure 6 : Global Market for HCAI Antibiotics, by Class (ATC Code), 2017-2023
Figure 7 : Global Market for HCAI Antibiotics, by Region, 2017-2023
Figure 8 : Global Market for HCAI Antifungals, by Class, 2017-2023
Figure 9 : Global Market for HCAI Antifungals, by Region, 2017-2023
Figure 10 : Global Market for Hepatitis B Therapeutics for HCAI, by Region, 2017-2023
Figure 11 : Global Market for Hepatitis B Vaccines for HCAI, by Region, 2017-2023
Figure 12 : Global Market for Hepatitis C Therapeutics for HCAI, by Region, 2017-2023
Figure 13 : Global Market for Influenza Vaccines for HCAI, by Region, 2017-2023
Figure 14 : Global Market for HCAI Environment Treatment, by Category, 2017-2023
Figure 15 : Global Market for Disinfectant Use in Hospitals, by Region, 2017-2023
Figure 16 : Global Market for Presurgical Skin Preparation, by Region, 2017-2023
Figure 17 : Global Market for Air-Filtration for Hospital Use, by Region, 2017-2023
Figure 18 : Global Market for High-Temperature Sterilization, by Region, 2017-2023
Figure 19 : Global Market for Low-Temperature Sterilization, by Category, 2017-2023
Figure 20 : Global Market for Low-Temperature Sterilization, by Region, 2017-2023
Figure 21 : Global Market for Radiation-based Sterilization, by Category, 2017-2023
Figure 22 : Global Market for Radiation-based Sterilization, by Region, 2017-2023
Figure 23 : Global Market for HCAI Medical Devices, by Category, 2017-2023
Figure 24 : Global Market for Coated Catheter, by Category, 2017-2023
Figure 25 : Global Market for Coated Catheter, by Region, 2017-2023
Figure 26 : Global Market for Coated Endotracheal Tube, by Region, 2017-2028
Figure 27 : Global Market for IV Filter, by Region, 2017-2023
Figure 28 : HCAI-Prevention Industry Structure

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report